VTV. I. Tkachenko

V. I. Tkachenko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


V. I. Tkachenko has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Results of surgical treatment of acute empyema of the pleura and its complications

    by V. V. Boyko, V. V. Tkachenko, A. L. Sochnieva, V. V. Kritsak, D. V. Minukhin, D. O. Yevtushenko, V. I. Tkachenko, V. I. Ponomarev, V. V. Ponomareva

    Objective. To summarize the results of treatment of acute empyema of pleurisy and its complications. Materials and methods. A generalized analysis of the results of conservative and surgical treatment of 426 patients with acute empyema of the pleura and its complications for the period 2008–2024 was performed. The dynamics of the disease course were determined taking into account laboratory and immunological indicators, the use of discrete plasmapheresis, and the microbial pathogen. Results. This study provided insight into the dynamics of the disease depending on its severity and microbial pathogen, and determined the need for conservative, minimally invasive thoracoscopic, and standard surgical treatment. Conclusions. Despite the rapid development of thoracic surgery, acute empyema of the pleura remains a serious disease with many complications in its course and surgical treatment. Identification of the microbial pathogen, laboratory and immunological indicators, and analysis of their dynamics allow us to judge the dynamics of the disease and serve as an additional marker in determining the indications for timely surgical treatment in combination with alternative conservative methods.

  • Open Access

    Bioresonance therapy in the rehabilitation of post−traumatic syndromes using the multiphysics device Muflon−X

    by M. I. Fyk, V. V. Tkachenko, А. Л. Sochnieva, V. V. Krytsak, V. I. Tkachenko, Ye. O. Tantsura

    Background: This study evaluates the clinical efficacy of bioresonance therapy (BRT) in the rehabilitation of patients with post−traumatic syndrome (PTS). Objective: To assess the impact of BRT using the MUFLON−X device on clinical, immunological, metabolic, and psycho−emotional parameters. Methods: A prospective randomized clinical trial was conducted involving patients. This study presents the results of a prospective randomized clinical trial evaluating the efficacy of bioresonance therapy (BRT) in the rehabilitation of 135 patients with post−traumatic syndrome (PTS). Conducted using the multiphysical device “Muflon−X,” developed at the National Technical University “Kharkiv Polytechnic Institute,” the trial compared three groups: standard treatment, BRT alone, and combined therapy. Clinical, immunological, metabolic, and psycho−emotional parameters were assessed. Results:. The combined therapy group demonstrated the most significant improvements, including reduced pain (VAS −5.6), improved sleep (PSQI +4.8), decreased inflammation (CRP −9.7 mg/L), and enhanced immune response (IgG +2.6 g/L, CD3+ +13.4%). Rehabilitation time was reduced by 49%, and medication costs decreased by up to 31%. Conclusions. The study highlights the potential of BRT as a non−invasive, adjunctive modality in PTS management, particularly in military and post−conflict settings. The combined therapy group showed the most significant improvements in pain reduction, sleep quality, inflammation markers, and immune response The findings support further investigation into long−term outcomes, neuroplasticity, and integration of BRT into clinical protocols. This research provides a methodological foundation for expanding the use of BRT in evidence−based rehabilitation medicine.


  • Open Access

    The importance of biomarkers in the diagnosis and monitoring of complicated course of acute pleural empyema

    by V. V. Boyko, A. L. Sochneva, V. V. Kritzak, P. I. Korzh, D. V. Minukhin, D. O. Yevtushenko, A. A. Serenko, V. I. Tkachenko

    Objective. To determine the value of biomarkers in the diagnosis and monitoring of complicated course of acute pleural empyema. Materials and Methods. We analyzed the results of treatment of 426 patients with acute pleural empyema for the period 2008–2022. This study included patients (n = 64) with clinical and laboratory signs of systemic inflammatory response syndrome and clinically proven infection that complicated the course of pleural empyema – sepsis (group 1), and patients (n = 63) with acute pleural empyema without signs of a systemic infectious process – without established sepsis (group 2). Results. The results of the study allowed us to form an idea of the importance of biomarkers in the diagnosis and monitoring of the complicated course of acute pleural empyema in different periods of complex treatment. Conclusions. The use of additional biomarkers reflecting specific pathological processes may become an important tool for making clinical decisions regarding the management of patients with sepsis.

  • Open Access

    Classical surgical treatment of acute pleural empyema

    by V. V. Boyko, A. L. Sochneva, V. V. Kritzak, P. I. Korzh, D. V. Minukhin, A. A. Serenko, D. O. Yevtushenko, V. I. Tkachenko

    Objective. To determine the need for open surgical treatment in patients with acute pleural empyema with and without the use of video thoracoscopic rehabilitation interventions. Materials and methods. We analyzed the results of treatment of 426 patients with acute pleural empyema in the period 2008–2022, of whom 109 (25.6%) required open surgery after pleural cavity rehabilitation. Results. This study allowed us to form an idea of the need for open surgery at different periods from the beginning of complex treatment of acute pleural empyema, the nature and extent of surgical interventions, complications and their consequences. Conclusions. The need for operations such as pneumonectomy and pleuropneumonectomy after the rehabilitation of the pleural cavity in acute pleural empyema remains at the level of 3.6–6.9%.